Mostrando 2 resultados de: 2
Filtros aplicados
Área temáticas
Enfermedades(2)
Fisiología humana(2)
Farmacología y terapéutica(1)
Salud y seguridad personal(1)
Año de Publicación
2007(2)
Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with frederickson type IV dyslipidemia phenotype
Conference ObjectAbstract: OBJECTIVE: The combination of hypertriglyceridemia and low high density lipoprotein (HDL) cholesteroPalabras claves:Ciprofibrate, Frederickson's type IV dyslipidemia, High density lipoprotein cholesterol, Hyperlipidemia, Low density lipoprotein cholesterol, Non-high density lipoprotein cholesterol, TriglyceridesAutores:Arráiz N., Bermúdez-Arias F., Cano-Peñaloza R., Cano-Ponce C., Contreras F., de Bravo M.C., De Diaz A.A., De Pirela N.L., Israili Z.H., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Puche-Medina G., Reyna-Villazmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusLipoprotein (a) in an urban population of Venezuela: Evidence that estrogenic deprivation increase in lipoprotein (A) levels is transitory
ArticleAbstract: Background: Lipoprotein (a) [Lp (a)] is an independent risk factor for coronary artery disease and nPalabras claves:Apo (a), Hormonal replacement therapy, Lipoprotein (a), risk factor, Tissue plasminogen activatorAutores:Amell De Díaz A., Cabrera De Bravo M.C., Cano-Ponce C., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Sorell Gómez L., Valmore BermúdezFuentes:scopus